The Glooko team is excited to join industry trailblazers in Chicago from April 13 to 16 for the Becker’s Healthcare 16th Annual Meeting. This flagship event brings together the brightest minds in health system leadership, and we look forward to connecting with the CEOs, CFOs, CNOs, and CIOs driving the next wave of clinical innovation.
With a focus on margin recovery, workforce stability, and AI adoption, we’ll showcase at booth 136 how we’re redefining the diabetes care continuum by moving away from fragmented, disconnected tools and toward a more unified diabetes ecosystem, integrated with the EHR, that supports patients in the hospital through the EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, and at home using the Glooko diabetes management platform.
“The Becker’s Healthcare 16th Annual Meeting is the perfect stage to showcase how Glooko is redefining the enterprise partnership through our digital health solutions designed to slash glycemic risk and lift the weight off the shoulders of overburdened diabetes care teams,” said Glooko CEO Mike Alvarez. “From the ground up, our inpatient and outpatient platforms spanning the entire care continuum are built for what matters most in modern healthcare: ironclad security, seamless interoperability with the EHR, core workflow optimizations, and a relentless focus on the clinician experience.”
Glooko: Transforming Outpatient Diabetes Management Through Data-Driven Care and Population Health Insights
In the outpatient setting, Glooko transforms diabetes management by optimizing ambulatory and endocrinology workflows. By seamlessly syncing with over 200 diabetes and health monitoring devices and apps, our platform eliminates data silos and fosters deeper remote collaboration between patients and care teams. This shift from reactive treatment to proactive, risk-based outreach empowers care teams to use our clinic dashboard to prioritize high-risk patients. The result is a more scalable, effective care model that optimizes population health management.
EndoTool: Reducing Hypoglycemia and Optimizing Inpatient Diabetes Care
On the inpatient side, EndoTool provides a sophisticated solution for precise glycemic management. By offering robust clinical decision support and standardized workflows, EndoTool empowers care teams to achieve safer insulin dosing while significantly improving operational efficiency. This automated approach reduces the manual burden on nursing staff and eliminates the risks associated with traditional sliding-scale protocols. By stabilizing blood glucose levels more rapidly and accurately, hospitals can drive measurable improvements in patient safety, like reducing the risk of severe hypoglycemia to virtually zero, and clinical quality metrics.
Experience our innovative diabetes digital health solutions at booth 136
See how Glooko and EndoTool advance interoperability, efficiency, and diabetes care continuity across inpatient and outpatient settings by scheduling a demo with our team.
EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.